Part of the problem was a lack of new research into drugs to treat TB and other drug-resistant forms of the disease. "Because the world thought we had defeated TB‚ there has been no new research for the past 50 years. It’s only now that we are waking up‚" said Motsoaledi.
According to a report by Bizcommunity‚ a Japanese drug-maker will supply SA free of charge to pilot one of the few new TB drugs to be developed in half a century.
The South African National TB Association (SANTA) community services manager, Peter Mabalane‚ said that a lack of funding for TB programmes and the conflation of TB and HIV‚ meant the problem of TB was not properly addressed. "TB is not getting the attention it deserves and is treated as a secondary disease to HIV‚" he said. "There is no need for people to die from TB because it is curable. We need a well funded unit that will liaise properly with non-governmental organisations and communities to fight TB."
Motsoaledi said the core infection rates for TB and HIV were very high‚ and the diseases could not be looked at in isolation. He said the strategy plan would deal with prevention‚ treatment, care and support, and will target key populations.
Source: Business Day